2021-05-28 06:06:16 BIG Big Lots
05/28/21 05/2806:06 05/28/2106:06 | Big Lots reports Q1 EPS $2.62, consensus $1.69Reports Q1 revenue $1.63B, consensus $1.53B. Reports 11.3% increase in comparable sales. Bruce Thorn, President and CEO of Big Lots stated, "We have completed a record first quarter that was driven both by our underlying Operation North Star strategic initiatives and by customer response to a third round of stimulus distributions that began in March. For the quarter, we saw double digit growth across all merchandise categories other than Food and Consumables, which were greatly bolstered last year by quarantine-related stock-up spending early in the pandemic. We also saw notable strength in our Seasonal assortment, particularly lawn & garden, while Broyhill, launched just last year, drove $225 million in sales for the quarter across our Furniture and Home assortments, continuing its rapid progress toward becoming an established $1 billion brand. Additionally, our ecommerce business grew 30%, and our Rewards program reached a record high number of active members. Our outstanding results for the quarter were achieved despite significant supply chain and freight headwinds, which we expect to continue through the balance of the year. Meanwhile, we are taking other important steps to strengthen our business. These include rolling out our forward distribution center strategy to relieve pressure at our regional distribution centers and more efficiently process bulk items such as furniture; strengthening our vendor partnerships to create even greater value for our customers and improve assortment availability; and investing in data-driven space planning technology designed to enhance our customer satisfaction and per-store productivity through more relevant location- based assortments. We are excited by our results, but know that we still have many opportunities for growth and improvement across the business. Big Lots is growing in a productive and sustainable manner and we are doing so knowing that our goal is to create the best value for our customer so that she can Live Big and Save Lots. Our growth is driven by our Operation North Star, but is fulfilled by our 37,000 associates across our stores, the distribution centers, and in our home office. I am so proud to be a member of this team and I am deeply thankful for their unwavering commitment." |
|
---|
Hot Stocks
|
Myriad Genetics to present multiple genetic studies in cancer treatment at ASCO »
19:04 05/26/22 05/2619:04 05/26/2219:04
MYGN
Myriad Genetics
The company states:… Story temporarily locked. ShowHide Related Items >><<
|
Earnings
|
Taro Pharmaceutical reports Q4 EPS 73c vs. (78c) last year »
19:01 05/26/22 05/2619:01 05/26/2219:01
TARO
Taro Pharmaceutical
Reports Q4 revenue… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Biomea Fusion to present new preclinical data on BMF-219 at ASCO »
19:00 05/26/22 05/2619:00 05/26/2219:00
BMEA
Biomea Fusion
Biomea Fusion… Story temporarily locked. ShowHide Related Items >><<
|
Recommendations
|
Equinix price target lowered to $770 from $825 at BMO Capital »
18:57 05/26/22 05/2618:57 05/26/2218:57
EQIX
Equinix
BMO Capital analyst Ari… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Mereo BioPharma to present updated Phase 1b/2 data on Etigilimab and Nivolumab »
18:57 05/26/22 05/2618:57 05/26/2218:57
MREO
Mereo BioPharma
Mereo BioPharma announced… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Affimed to present on three AFM24 clinical trial designs at ASCO 2022 »
18:55 05/26/22 05/2618:55 05/26/2218:55
AFMD
Affimed
Affimed announced that… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Oncternal Therapeutics presents interim data for Zilovertamab+Ibrutinib at ASCO »
18:51 05/26/22 05/2618:51 05/26/2218:51
ONCT
Oncternal Therapeutics
Oncternal Therapeutics… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Puma Biotechnology to present two abstracts on neratinib at ASCO Meeting »
18:49 05/26/22 05/2618:49 05/26/2218:49
PBYI
Puma Biotechnology
Puma Biotechnology… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Invitae to present eight studies at ASCO »
18:48 05/26/22 05/2618:48 05/26/2218:48
NVTA
Invitae
Invitae "announced… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Arbutus Biopharma to present data from preclinical study of PD-L1 inhibitor »
18:47 05/26/22 05/2618:47 05/26/2218:47
ABUS
Arbutus Biopharma
Arbutus Biopharma's… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Elevation Oncology to present initial Seribantumab data at ASCO »
18:46 05/26/22 05/2618:46 05/26/2218:46
ELEV
Elevation Oncology
Elevation Oncology… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
PDS Biotechnology announces presentation of Phase 2 data on PDS0101 at ASCO »
18:42 05/26/22 05/2618:42 05/26/2218:42
PDSB
PDS Biotechnology
PDS Biotechnology… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Gracell to present updated clinical data on GC012F in multiple myeloma »
18:40 05/26/22 05/2618:40 05/26/2218:40
GRCL
Gracell
Gracell Biotechnologies… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
SpringsWorks Therapeutics presents Nirogacestat Clinical Data at 2022 ASCO »
18:39 05/26/22 05/2618:39 05/26/2218:39
SWTX
SpringsWorks Therapeutics
GlaxoSmithKline
SpringWorks Therapeutics… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Alaunos Therapeutics to present data on TCR-T Library Phase 1/2 trial »
18:36 05/26/22 05/2618:36 05/26/2218:36
TCRT
Alaunos Therapeutics
Alaunos Therapeutics… Story temporarily locked. ShowHide Related Items >><<
|
Earnings
|
Loop Industries reports FY22 EPS (99c), consensus (88c) »
18:36 05/26/22 05/2618:36 05/26/2218:36
LOOP
Loop Industries
Daniel Solomita, Founder… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Xencor reports initial dose-escalation Phase 1 data of XmAb 104 »
18:32 05/26/22 05/2618:32 05/26/2218:32
XNCR
Xencor
Xencor reported initial… Story temporarily locked. ShowHide Related Items >><<
|
On The Fly
|
Fly Intel: After-Hours Movers »
18:31 05/26/22 05/2618:31 05/26/2218:31
RRGB
Red Robin
Ulta Beauty
Dell Technologies
Marvell
Autodesk
Adicet Bio
PMV Pharmaceuticals
Zymeworks
PDS Biotechnology
Gap
American Eagle
Workday
Costco
Iovance Biotherapeutics
SpringsWorks Therapeutics
Mirati Therapeutics
ShowHide Related Items >><<
|
Hot Stocks
|
Spectrum to present data on poziotinib in NSCLC at ASCO Meeting »
18:28 05/26/22 05/2618:28 05/26/2218:28
SPPI
Spectrum
Spectrum Pharmaceuticals… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Amgen to present new data from oncology pipeline at ASCO »
18:26 05/26/22 05/2618:26 05/26/2218:26
AMGN
Amgen
Takeda Pharmaceutical
Results From the PARADIGM… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Eli Lilly to present data on oncology portfolio »
18:21 05/26/22 05/2618:21 05/26/2218:21
LLY
Eli Lilly
Eli Lilly announced that… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
CTI BioPharma to present pivotal data on pacritinib program »
18:19 05/26/22 05/2618:19 05/26/2218:19
CTIC
CTI BioPharma
CTI BioPharma announced a… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Cue Biopharma to present interim data on CUE-101 in head and neck cancer »
18:17 05/26/22 05/2618:17 05/26/2218:17
CUE
Cue Biopharma
Cue Biopharma will give a… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Ipsen's Cabometyx shows 'encouraging' efficacy results in different tumor types »
18:15 05/26/22 05/2618:15 05/26/2218:15
IPSEY
Ipsen
Ipsen announced… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Checkmate Pharmaceuticals vidutolimod data to be presented at ASCO »
18:13 05/26/22 05/2618:13 05/26/2218:13
CMPI
Checkmate Pharmaceuticals
Checkmate Pharmaceuticals… Story temporarily locked. ShowHide Related Items >><<
|